Hospital Floors May Be Breeding Ground for Superbugs

This article originally appeared here.
Share this content:
Hospital Floors May Be Breeding Ground for Superbugs
Hospital Floors May Be Breeding Ground for Superbugs

FRIDAY, March 3, 2017 (HealthDay News) -- Hospital room floors may be more of an infection threat than many hospital staffers realize, according to a study published in the March 1 issue of the American Journal of Infection Control.

Researchers took samples from the floors of 159 patient rooms in five Cleveland-area hospitals and found that many were contaminated with health care-associated pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Clostridium difficile.

The researchers also found that 41 percent of patient-occupied rooms had one or more "high-touch" objects in contact with the floor, including personal items, medical devices, and medical supplies. MRSA, VRE and C. difficile were found on 18, 6, and 3 percent, respectively, of bare or gloved hands that handled the items.

"We found that floors in patient rooms were frequently contaminated with health care-associated pathogens and demonstrated the potential for indirect transfer of pathogens to hands from fomites placed on the floor," the authors write. "Further studies are needed to investigate the potential for contaminated hospital floors to contribute to pathogen transmission."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths